Post-Marketing Non-Acute Safety Study in Japan After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons at High Risk of Severe COVID-19

NCT05894590 · clinicaltrials.gov ↗
COMPLETED
Status
13680
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

ModernaTX, Inc.